ANIXA BIOSCIENCES, INC. Increase Decrease In Operating Lease Liability
ANIXA BIOSCIENCES, INC. (ANIX) reported Increase Decrease In Operating Lease Liability of -$30.00 thousand for the 9-month period ending 2026-07-31, per its 10-Q filed 2026-09-09.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-09-09
- ANIXA BIOSCIENCES, INC. increase decrease in operating lease liability for the quarter ending 2026-07-31 was -$10.00K.
- ANIXA BIOSCIENCES, INC. increase decrease in operating lease liability for the quarter ending 2026-04-30 was -$9.00K.
- ANIXA BIOSCIENCES, INC. increase decrease in operating lease liability for the quarter ending 2026-01-31 was -$11.00K.
- ANIXA BIOSCIENCES, INC. increase decrease in operating lease liability for the quarter ending 2025-10-31 was -$9.00K.
- ANIXA BIOSCIENCES, INC. increase decrease in operating lease liability for fiscal 2025 was -$28.00K.
- ANIXA BIOSCIENCES, INC. increase decrease in operating lease liability for fiscal 2024 was -$43.00K.
- ANIXA BIOSCIENCES, INC. increase decrease in operating lease liability for fiscal 2023 was -$46.00K.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-07-31 | -$10.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-09-09 | -$19.00K derived: sum of 2 quarters · filed 2026-09-09 | -$30.00K 10-Q · filed 2026-09-09 | -$39.00K derived: sum of 4 quarters · filed 2026-09-09 |
| 2026-04-30 | -$9.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-06-10 | -$20.00K 10-Q · filed 2026-06-10 | -$29.00K derived: sum of 3 quarters · filed 2026-06-10 | -$37.00K derived: sum of 4 quarters · filed 2026-09-09 |
| 2026-01-31 | -$11.00K 10-Q · filed 2026-03-09 | -$20.00K derived: sum of 2 quarters · filed 2026-03-09 | -$28.00K derived: sum of 3 quarters · filed 2026-09-09 | -$37.00K derived: sum of 4 quarters · filed 2026-09-09 |
| 2025-10-31 | -$9.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-01-12 | -$17.00K derived: sum of 2 quarters · filed 2026-09-09 | -$26.00K derived: sum of 3 quarters · filed 2026-09-09 | -$28.00K 10-K · filed 2026-01-12 |
| 2025-07-31 | -$8.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-09-09 | -$17.00K derived: sum of 2 quarters · filed 2026-09-09 | -$19.00K 10-Q · filed 2026-09-09 | -$24.00K derived: sum of 4 quarters · filed 2026-09-09 |
| 2025-04-30 | -$9.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-06-10 | -$11.00K 10-Q · filed 2026-06-10 | -$16.00K derived: sum of 3 quarters · filed 2026-06-10 | -$28.00K derived: sum of 4 quarters · filed 2026-06-10 |
| 2025-01-31 | -$2.00K 10-Q · filed 2026-03-09 | -$7.00K derived: sum of 2 quarters · filed 2026-03-09 | -$19.00K derived: sum of 3 quarters · filed 2026-03-09 | -$32.00K derived: sum of 4 quarters · filed 2026-03-09 |
| 2024-10-31 | -$5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-01-12 | -$17.00K derived: sum of 2 quarters · filed 2026-01-12 | -$30.00K derived: sum of 3 quarters · filed 2026-01-12 | -$43.00K 10-K · filed 2026-01-12 |
| 2024-07-31 | -$12.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-09-10 | -$25.00K derived: sum of 2 quarters · filed 2025-09-10 | -$38.00K 10-Q · filed 2025-09-10 | -$50.00K derived: sum of 4 quarters · filed 2025-09-10 |
| 2024-04-30 | -$13.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-05-28 | -$26.00K 10-Q · filed 2025-05-28 | -$38.00K derived: sum of 3 quarters · filed 2025-05-28 | -$50.00K derived: sum of 4 quarters · filed 2025-05-28 |
| 2024-01-31 | -$13.00K 10-Q · filed 2025-03-11 | -$25.00K derived: sum of 2 quarters · filed 2025-03-11 | -$37.00K derived: sum of 3 quarters · filed 2025-03-11 | -$47.00K derived: sum of 4 quarters · filed 2025-03-11 |
| 2023-10-31 | -$12.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-01-10 | -$24.00K derived: sum of 2 quarters · filed 2025-01-10 | -$34.00K derived: sum of 3 quarters · filed 2025-01-10 | -$46.00K 10-K · filed 2025-01-10 |
| 2023-07-31 | -$12.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-09-06 | -$22.00K derived: sum of 2 quarters · filed 2024-09-06 | -$34.00K 10-Q · filed 2024-09-06 | |
| 2023-04-30 | -$10.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-06-04 | -$22.00K 10-Q · filed 2024-06-04 | ||
| 2023-01-31 | -$12.00K 10-Q · filed 2024-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 |